Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02309814
Other study ID # 0133-13-EMC
Secondary ID
Status Completed
Phase N/A
First received December 1, 2014
Last updated September 7, 2016
Start date January 2015
Est. completion date August 2016

Study information

Verified date September 2016
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

The investigators have developed a simple to use device that facilitates the monitoring of the upper eyelids motion, acquires the eyelid vertical movement and enables analysis and graphic presentation of the results. the device system consists 3 components : glasses for the patient including magneto sensitive probes, hardware and dedicated software.

Our purpose is to characterize eyelid motion in normal population. The methods include measuring each patient 10 minutes during watching a short movie.


Description:

Essentially, for Hall-probes monitor the magnetic field generated by a tiny magnets attached to the upper eyelid.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 67 Years
Eligibility Inclusion Criteria:

- healthy 18-67 year olds with no eye medical history

Exclusion Criteria:

- pregnancy

- head trauma history

- using contact lens

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Device:
eyelid motion sensor device (Hall-probe)
all volunteers will wear the eyelid motion sensor device (Hall-probe) (including the tiny magnets on the upper eyelid). a 10 minutes movie will be screened on 40 inch television screen in a 3 meters distance

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Outcome

Type Measure Description Time frame Safety issue
Primary Demonstrate and describe measurable blinking character in normal population.(Hall-probes monitor the magnetic field generated by a tiny magnets attached to the upper eyelid) 10 minutes No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03396627 - Müller's Muscle as a New Proprioceptive Organ N/A
Recruiting NCT05945069 - Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects With Dry Eye Disease N/A